Phoslock Environmental Technologies has advanced a new range of lanthanum-enhanced phosphorus-binding products showing up to four times the capacity of current offerings, with pilot and manufacturing tests confirming strong performance and low lanthanum release. Field trials are underway, aiming for commercial sales in 2027.
- New products contain 10%-25% lanthanum versus 5% in existing Phoslock
- Pilot tests show up to 4x phosphorus-binding capacity
- Manufacturing validation completed on existing plant with minor tweaks
- Field testing commenced in USA and planned in China
- Potential for improved margins, lower dosage, and expanded market share
Significant Boost in Phosphorus-Binding Capacity
Phoslock Environmental Technologies Limited (ASX:PET) has unveiled a new family of clay-based phosphorus-binding products featuring lanthanum concentrations ranging from 10% to 25%, a marked increase from the 5% lanthanum in its flagship Phoslock product. Laboratory pilot-scale testing has revealed these new formulations can achieve phosphorus-binding capacities close to their theoretical limits, with the 20% lanthanum variant demonstrating roughly four times the binding capacity of the existing product.
Crucially, these enhanced products maintain low levels of free lanthanum ion release into treated waters, addressing environmental and regulatory concerns that often accompany increased lanthanum content. This balance of high performance and controlled lanthanum release represents a potentially transformative advance in water treatment chemistry.
Manufacturing Validation Supports Scale-Up Without Major Capex
In a strategic milestone, Phoslock successfully produced a 2-tonne test batch of the 10% lanthanum product using its current commercial manufacturing plant, requiring only minor modifications. Laboratory testing confirmed that the production batch retained the phosphorus-binding and lanthanum release characteristics seen in pilot tests. The company plans additional 2-tonne runs for the 10% product and the higher-capacity 20% product in September.
This capability to leverage existing manufacturing infrastructure could allow Phoslock to scale up production efficiently, sidestepping the need for costly new facilities. This is particularly significant given the company’s recent efforts to ramp production amid ongoing operational and legal challenges, as it seeks to stabilise its cash flow and market position.
Transitioning to Field Trials in Key Markets
The development program is advancing beyond laboratory and production validation into field testing. A 1-tonne batch of the 10% lanthanum product has been dispatched to the USA for pond testing overseen by Orion, one of Phoslock’s established partners. Concurrently, a fishpond trial is scheduled in Shanghai, China, with independent researchers conducting sampling and analysis to provide external validation.
These field trials represent crucial steps toward commercial deployment, expected to provide real-world evidence of the products’ efficacy and environmental safety. While commercial success remains uncertain, Phoslock anticipates potential first sales in 2027 if testing outcomes are favourable.
Potential to Reshape Economics and Competitive Position
The new product family could fundamentally alter the economics of phosphorus removal for both Phoslock and its customers. By delivering substantially higher phosphorus-binding capacity, the company expects to reduce dosage requirements and product volumes needed per project. This could translate into lower logistics and application costs, a critical factor in water treatment projects where transportation and handling expenses are significant.
Although manufacturing costs per tonne are likely to increase due to higher lanthanum content, Phoslock believes it can command premium pricing that exceeds these cost rises, improving gross margins. Enhanced margins combined with the possibility of expanded market penetration could drive meaningful profit growth and strengthen the company’s competitive position, enabling entry into markets previously less commercially viable.
Moreover, the improved efficiency may delay the need for major manufacturing capacity expansions, preserving capital and operational flexibility.
Patent Protection and Strategic Implications
Phoslock has filed a patent application to safeguard its intellectual property related to this new product family, signalling the strategic importance of this innovation. If commercialised successfully, these products could represent a step-change in the company’s long-term growth trajectory, potentially transforming its market footprint and profitability.
However, the company remains cautious, acknowledging that field testing and commercialisation carry inherent risks and there is no guarantee of success. The next phases of bulk field testing and market acceptance will be pivotal in validating laboratory results under real-world conditions.
Bottom Line?
Phoslock’s new lanthanum-enhanced products could redefine phosphorus removal economics, but upcoming field trials will be critical to confirm their commercial viability.
Questions in the middle?
- Will field testing in the USA and China confirm laboratory performance at scale?
- How will Phoslock balance increased manufacturing costs with premium pricing strategies?
- Can the company leverage existing manufacturing capacity to meet potential demand growth?